Rapid Optimisation of Performance Enhancement and Skill (ROPES)
Launched by SINGAPORE GENERAL HOSPITAL · Dec 22, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The ROPES trial is exploring a new exercise program designed to help people who have not been active find easier ways to incorporate physical activity into their daily lives. Many healthcare workers, like everyone else, struggle to stay active, even though they know it’s important for their health. This study aims to create a short and effective training program that fits into busy schedules, making it simpler for participants to start exercising regularly.
To participate in this trial, you need to be between 21 and 70 years old and currently not exercising regularly—meaning you work out less than once a week for less than 30 minutes each time. You should also be in good health, without any recent injuries or serious medical conditions. If you join, you can expect a supportive environment where the focus is on making exercise enjoyable and manageable. Remember, this trial is actively recruiting participants, so if you or someone you know fits the criteria and is interested in becoming more active, this could be a great opportunity!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age group: 21 - 70 years old
- • All participants must be free of musculoskeletal, surgical and/or neurological injury in the past 6 months.
- • Participants not engaged actively in regular exercise i.e. exercises less than once a week and at a duration less than 30 mins per session.
- • Healthy with stable management of any existing diabetes, cholesterol and/or hypertension.
- • They should have no issues with the Physical Activity Readiness Questionnaire (PAR-Q)
- Exclusion Criteria:
- • Participants under the age of 21 or over the age of 70
- • Newly diagnosed diabetes/metabolic syndrome/high cholesterol or uncontrolled high BP \>160 mmHg and under medical supervision.
- • Subjects with cardiovascular conditions and on beta-blockers.
- • Subjects who are pregnant or with recent (\< 3 months) diagnosis of a medical condition, especially cardiac-related conditions.
About Singapore General Hospital
Singapore General Hospital (SGH) is a leading academic medical center in Singapore, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SGH plays a pivotal role in conducting cutting-edge studies that aim to improve patient outcomes and enhance medical knowledge across various specialties. With a strong focus on collaboration and multidisciplinary approaches, SGH leverages its extensive resources and expertise to facilitate rigorous clinical trials, ensuring the highest standards of safety and efficacy in the development of new treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported